Literature DB >> 11784218

National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.

Elbert S Huang1, Randall S Stafford.   

Abstract

BACKGROUND: Trimethoprim-sulfamethoxazole has consistently been the recommended drug for uncomplicated urinary tract infections in women. Which antibiotics physicians use has implications for patient outcomes, antimicrobial resistance, and costs.
METHODS: This study was based on a sample survey of practicing physicians participating in the National Ambulatory Medical Care Survey from 1989 through 1998. Eligible visits were limited to those by women aged 18 to 75 years diagnosed with uncomplicated acute cystitis or urinary tract infection (N = 1478). We evaluated trends in the proportions of visits at which physicians prescribed (1) trimethoprim-sulfamethoxazole, (2) recommended fluoroquinolones, (3) nitrofurantoin, and (4) nonrecommended antibiotics (neither trimethoprim-sulfamethoxazole nor recommended fluoroquinolones). We also identified predictors of specific antibiotic prescribing among visits to primary care physicians.
RESULTS: The most frequently prescribed antibiotics were trimethoprim-sulfamethoxazole, recommended fluoroquinolones, and nitrofurantoin. We found that the proportion of trimethoprim-sulfamethoxazole prescriptions declined from 48% in 1989-1990 to 24% in 1997-1998 (adjusted odds ratio [OR], 0.33; 95% confidence interval [CI], 0.21-0.52 per decade). Conversely, fluoroquinolone use increased (19% to 29%) (OR, 2.28; 95% CI, 1.35-3.83) as did nitrofurantoin prescribing (14% to 30%) (OR, 2.44; 95% CI, 1.44-4.13). Among primary care physicians, internists were the most likely to prescribe fluoroquinolones while obstetricians were the most likely to use nitrofurantoin.
CONCLUSIONS: Ambulatory care physicians are increasing their use of fluoroquinolones and nitrofurantoin, even though they are not highly recommended and not the most cost-effective. Antibiotic prescribing in urinary tract infections may be influenced by clinical factors such as pregnancy and drug allergies but may also be shaped by nonclinical factors such as subspecialty culture.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11784218     DOI: 10.1001/archinte.162.1.41

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  37 in total

1.  Treating UTIs in reproductive-age women-proceed with caution.

Authors:  Jean Moon; Shailendra Prasad; Mari Egan
Journal:  J Fam Pract       Date:  2010-04       Impact factor: 0.493

2.  Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.

Authors:  Thomas M Hooton; Pacita L Roberts; Ann E Stapleton
Journal:  JAMA       Date:  2012-02-08       Impact factor: 56.272

3.  Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.

Authors:  James A Karlowsky; Daryl J Hoban; Melanie R Decorby; Nancy M Laing; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Duration of antibiotic therapy in pyelonephritis: when shorter is better.

Authors:  Elisa Russo; Francesca Viazzi
Journal:  Intern Emerg Med       Date:  2020-07-14       Impact factor: 3.397

5.  Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas.

Authors:  J-Y Wang; P-R Hsueh; I-S Jan; L-N Lee; Y-S Liaw; P-C Yang; K-T Luh
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 6.  Urinary tract infections in adult general practice patients.

Authors:  Eva Hummers-Pradier; Michael M Kochen
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

7.  Urinary tract infection in women--physician's preferences for treatment and adherence to guidelines: a national drug utilization study in a managed care setting.

Authors:  Ernesto Kahan; Natan R Kahan; David P Chinitz
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

8.  Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.

Authors:  James A Karlowsky; Laurie J Kelly; Clyde Thornsberry; Mark E Jones; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007.

Authors:  L Blaettler; D Mertz; R Frei; L Elzi; A F Widmer; M Battegay; U Flückiger
Journal:  Infection       Date:  2009-12       Impact factor: 3.553

10.  Community-acquired antibiotic resistance in urinary isolates from adult women in Canada.

Authors:  Warren J McIsaac; Tony Mazzulli; Joanne Permaul; Rahim Moineddin; Donald E Low
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-11       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.